Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia.

Liu C, Kawedia JD, Cheng C, Pei D, Fernandez CA, Cai X, Crews KR, Kaste SC, Panetta JC, Bowman WP, Jeha S, Sandlund JT, Evans WE, Pui CH, Relling MV.

Leukemia. 2012 Nov;26(11):2303-9. doi: 10.1038/leu.2012.102. Epub 2012 Apr 9.

2.

How to manage asparaginase hypersensitivity in acute lymphoblastic leukemia.

Burke MJ.

Future Oncol. 2014 Dec;10(16):2615-27. doi: 10.2217/fon.14.138. Review.

3.

Erwinia asparaginase in pediatric acute lymphoblastic leukemia.

Salzer W, Seibel N, Smith M.

Expert Opin Biol Ther. 2012 Oct;12(10):1407-14. doi: 10.1517/14712598.2012.718327. Epub 2012 Sep 4. Review.

PMID:
22946493
4.

Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance.

Chen SH.

Pediatr Neonatol. 2015 Oct;56(5):287-93. doi: 10.1016/j.pedneo.2014.10.006. Epub 2014 Dec 23. Review.

5.

L-asparaginase and venous thromboembolism in acute lymphocytic leukemia.

Goyal G, Bhatt VR.

Future Oncol. 2015;11(17):2459-70. doi: 10.2217/fon.15.114. Epub 2015 Aug 14. Review.

6.

[Progress in researches on L-asparaginase targeted to childhood leukemia].

Cui YQ, Chen FX, Wu ZL.

Zhonghua Er Ke Za Zhi. 2004 Mar;42(3):227-30. Review. Chinese. No abstract available.

PMID:
15144726
7.

Development of asparaginase Erwinia chrysanthemi for the treatment of acute lymphoblastic leukemia.

Salzer WL, Asselin BL, Plourde PV, Corn T, Hunger SP.

Ann N Y Acad Sci. 2014 Nov;1329:81-92. doi: 10.1111/nyas.12496. Epub 2014 Aug 5. Review.

8.

Best Practices in Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia: A Focus on Asparaginase.

Boissel N, Sender LS.

J Adolesc Young Adult Oncol. 2015 Sep;4(3):118-28. doi: 10.1089/jayao.2015.0014. Review.

9.
10.

Asparaginase in acute lymphoblastic leukemia.

Kawedia JD, Rytting ME.

Clin Lymphoma Myeloma Leuk. 2014 Sep;14 Suppl:S14-7. doi: 10.1016/j.clml.2014.06.017. Review.

PMID:
25486949
11.

L-asparaginase as a critical component to combat Acute Lymphoblastic Leukaemia (ALL): A novel approach to target ALL.

Ali U, Naveed M, Ullah A, Ali K, Shah SA, Fahad S, Mumtaz AS.

Eur J Pharmacol. 2016 Jan 15;771:199-210. doi: 10.1016/j.ejphar.2015.12.023. Epub 2015 Dec 15. Review.

PMID:
26698391

Supplemental Content

Support Center